Oxybutynin can reduce hot flashes in breast cancer survivors

10 Dec 2018


Research, presented at the San Antonio Breast Cancer Symposium, suggests that the drug oxybutynin can reduce the severity of hot flashes in patients who have had breast cancer. 

Healio


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story